Serum inorganic fluoride concentrations and renal function with sevoflurane or enflurane anaesthesia in patients without renal disease: A phase III, open-label, randomised, comparative study;SERUMFLUORIDKONZENTRATIONEN UND EXOKRINE NIERENFUNKTION BEI ANWENDUNG VON SEVOFLURAN UND ENFLURAN. EINE OFFENE, RANDOMISIERTE, VERGLEICHENDE PHASE III - STUDIE AN NIERENGESUNDEN PATIENTEN

Anaesthesist

Volumn 45, Issue 1, 1996, Pages 31-36

  Wiesner, G ^a   Wild, K ^a   Schwurzer S ^a   Merz, M ^a   Hobbhahn, J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

enflurane; fluoride; renal function; sevoflurane

Indexed keywords

ENFLURANE; FENTANYL; FLUORIDE; NITROUS OXIDE; SEVOFLURANE; THIOPENTAL; VECURONIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL ANESTHESIA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANESTHETICS, INHALATION; ENFLURANE; ETHERS; FEMALE; FLUORIDES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; METHYL ETHERS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0030069205     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050237     Document Type: Article

References (21)

1. Cousins MJ, Mazze RI (1973) Methoxyflurane nephrotoxicity: A study of dose-reponse in man. JAMA 225: 1611-1616
2. Frink EJ Jr, Ghantous H, Malan P, Morgan S, Fernando J, Gandolfi AJ, Brown BR Jr (1992) Plasma inorganic fluoride with sevoflurane anesthesia: Correlation with indices of hepatic and renal function. Anesth Analg 74: 231-235
3. Frink EJ Jr, Malan TP, Atlas M, Dominguez LM, DiNardo JA, Brown BR Jr (1992) Clinical comparison of Sevoflurane and Isoflurane in healthy patients. Anesth Analg 74: 241-245
4. Frink EJ Jr, Malan P Jr, Brown EA, Morgan S, Brown BR Jr (1993) Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and non-obese patients. Anesth Analg 76: 1333-1337
5. Frink EJ Jr, Malan TP Jr, Isner RJ, Brown EA, Morgan SE, Brown BR Jr (1994) Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology 80: 1019-1025
6. Furuya Y, Tachibana C, Kobayashi N, Fukada T, Sato K, Ohe Y (1993) Comparison of sevoflurane and halothane in pediatric anesthesia. Masui 42: 46-51
7. Higuchi H, Satoh T, Arimura S, Kanno M, Endoh R (1993) Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia. Anesth Analg 77: 1018-1021
8. Katoh T, Ikeda K (1987) The minimum alveolar concentration (MAC) of Sevoflurane in humans. Anesthesiology 66: 301-303
9. Kobayashi Y, Ochiai R, Takeda J, Sekiguchi H, Fukushima K (1992) Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. Anesth Analg 74: 753-757
10. Malviya S, Lerman J (1990) The blood/ gas solubilities of Sevoflurane, Isoflurane Halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 72: 793-796
11. Mazze RI, Calverley RK, Smith NT (1977) Inorganic fluoride nephrotoxicity: Prolonged Enflurane and Halothane anesthesia in volunteers. Anesthesiology 46: 265-271
12. Naito Y, Tamai S, Shingu K, Fujimori R, Mori K (1991) Comparison between Sevoflurane and Halothane for paediatric ambulatory anesthesia. Br J Anaesth 67: 387-389
13. Quasha AL, Eger EI II, Tinker JH (1980) Determination and application of MAC. Anesthesiology 53: 315-334
14. Ramm B, Hofmann G (1982) Biomathematik und medizinische Statistik, 2. Aufl. Enke, Stuttgart
15. Shiraishi Y, Ikeda K (1990) Uptake and biotransformation of sevoflurane in humans: a comparative study of sevoflurane with halothane, enflurane and isoflurane. J Clin Anesth 2: 381-386
16. 2O anesthesia. Anesth Analg 74: 253-259
17. Strum DP, Eger EI II (1987) Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 66: 654-656
18. Wallin RF, Regan BM, Napoli MD, Stern IJ, Grove M (1975) Sevoflurane: a new inhalation anesthetic agent. Anesth Analg 54: 758-765
19. Wiesner O, Schwürzer S, Hörauf K, Hobbhahn J (1994) Aufwachzeiten, Kreislaufverhalten und unerwünschte Wirkungen bei Anwendung von Sevofluran und Isofluran: Eine offene, randomisierte, vergleichende Phase III - Studie. Anaesthesist 43: 587-593
20. Wiesner G, Wild K, Merz M, Hobbhahn J (1994) Aufwachzeiten, Kreislaufverhalten und unerwünschte Wirkungen bei Anwendung von Sevofluran und Enfluran: Eine offene, randomisierte, vergleichende Phase III - Studie. Anästhesiol Intensivmed Notfallmed Schmerzther
21. Yasuda N, Eger EI II, Weiskopf RB, Tanifuji Y, Kobayashi K (1991) Solubility of desflurane (I-653), sevoflurane, isoflurane, and halothane in human blood. Masui 40: 1059-1062